Tirzepatide for managing overweight and obesity [ID6179]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 30 October 2024
Overweight and obesity managementStatus:In developmentProgramme:NICE guidelineExpected publication date: TBC
Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC